Shilpa Medicare arm secures USFDA orphan drug tag for rare blood cancer biologic

January 28, 2026
Uncategorized

Shilpa Biologicals and mAbTree Biologics received USFDA Orphan Drug Designation for a monoclonal antibody targeting Essential Thrombocythemia and Polycythemia Vera, advancing clinical trials.

Shilpa Medicare arm secures USFDA orphan drug tag for rare blood cancer biologic

Leave a ReplyCancel Reply

Oil prices may stay supported as Russian supply remains off market: Energy Aspects

HAL to set up final assembly line in India for Russia’s SJ100 passenger jet

Maharashtra Seamless Q3 profit jumps 31% despite revenue slump and margin squeeze

M&M Financial Q3 Results: Profit beats estimates, asset quality improves

Silver’s rally raises timing risks: ICICI Prudential AMC explains how to invest in the metal now